➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
AstraZeneca
McKesson
Express Scripts
Mallinckrodt

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CALCIUM DISODIUM VERSENATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Calcium Disodium Versenate, and when can generic versions of Calcium Disodium Versenate launch?

Calcium Disodium Versenate is a drug marketed by Medicis and is included in one NDA.

The generic ingredient in CALCIUM DISODIUM VERSENATE is edetate calcium disodium. There are two drug master file entries for this compound. Additional details are available on the edetate calcium disodium profile page.

Drug patent expirations by year for CALCIUM DISODIUM VERSENATE
Drug Prices for CALCIUM DISODIUM VERSENATE

See drug prices for CALCIUM DISODIUM VERSENATE

Recent Clinical Trials for CALCIUM DISODIUM VERSENATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
M.D. Anderson Cancer CenterPhase 2
Mt. Sinai Medical Center, MiamiPhase 4

See all CALCIUM DISODIUM VERSENATE clinical trials

US Patents and Regulatory Information for CALCIUM DISODIUM VERSENATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis CALCIUM DISODIUM VERSENATE edetate calcium disodium INJECTABLE;INJECTION 008922-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Medicis CALCIUM DISODIUM VERSENATE edetate calcium disodium TABLET;ORAL 008922-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
AstraZeneca
Moodys
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.